Generated: December 11, 2017
DrugPatentWatch Database Preview
Details for Patent: 8,162,915
« Back to Dashboard
Which drugs does patent 8,162,915 protect, and when does it expire?
Summary for Patent: 8,162,915
|Title:||Connector for packings containing medical liquids, and corresponding packing for medical liquids|
|Abstract:|| A connector for packings containing medical liquids, particularly infusion, transfusion or enteral bags, comprises a connecting part (1) for accommodating a spike for drawing out the liquid and comprises a closure part (3) that closes the passage (2) inside the connecting part (1). The connecting part (1) has an elastically deformable pinching off part (4) provided in the form of a tubular section with a non-circular cross-section. A base part (5), which widens on both sides is adjoined to said pinching off part (4) and can be integrated in the packing. During manufacturing, the packing is filled with liquid via the connecting part. After filling, the pinching off part is pressed together whereby preventing liquid from escaping. Afterwards, the closure part is placed onto the connecting part. The manufacturing of the packing is simplified by virtue of the fact that an additional tube for connecting the connector and packing is rendered unnecessary.|
|Inventor(s):|| Brandenburger; Torsten (Niddatal, DE), Heilmann; Klaus (St. Wendel, DE), Knierbein; Bernd (Neu-Anspach, DE) |
|Assignee:|| Fresenius Kabi Deutschland GmbH (Bad Homburg, DE) |
Patent Claim Types:|
see list of patent claims
Foreign Priority and PCT Information for Patent: 8,162,915
|Foriegn Application Priority Data|
||Foreign Patent Number
||Foreign Patent Date
|Germany||103 13 760||Mar 27, 2003|
|PCT Filed||January 22, 2004||PCT Application Number:||PCT/EP2004/000487|
|PCT Publication Date:||October 07, 2004||PCT Publication Number:||
International Patent Family for Patent: 8,162,915
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws,
it is advisable to have patent counsel verify freedom to operate.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.